Immunome, Inc. · NASDAQ:IMNM
Lechleider Robert sold 55,000 Immunome, Inc. shares (Form 4)
Traded Jun 25, 2026 · Filed Jun 29, 2026
On Jun 25, 2026, Lechleider Robert (Chief Medical Officer) sold 55,000 Immunome, Inc. shares at an average US$19.85 for US$1.09M under a trading plan, leaving 15,805 shares. Filed Jun 29, 2026 (Form 4).
- Sold
- 55,000 shares
- Price
- US$19.85 average (US$19.56 to US$20.66)
- Value
- US$1.09M
- Holding after
- 15,805 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | Option exercise | 55,000 | US$8.73 | 70,805 | Direct |
| Jun 25, 2026 | Common Stock | Sale | 40,580 | US$19.56 | 30,225 | Direct |
| Jun 25, 2026 | Common Stock | Sale | 14,420 | US$20.66 | 15,805 | Direct |
Source
Related
- Immunome, Inc.
- Lechleider Robert
- Immunome, Inc. shareholders
- Form 4 · Lechleider Robert · Jul 27, 2026
- Form 4 · Lechleider Robert · Jul 7, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026